• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童多发性硬化症:125例患者的临床概况

Multiple sclerosis in childhood: clinical profile in 125 patients.

作者信息

Duquette P, Murray T J, Pleines J, Ebers G C, Sadovnick D, Weldon P, Warren S, Paty D W, Upton A, Hader W

出版信息

J Pediatr. 1987 Sep;111(3):359-63. doi: 10.1016/s0022-3476(87)80454-7.

DOI:10.1016/s0022-3476(87)80454-7
PMID:3625402
Abstract

Multiple sclerosis (MS) has its usual onset in early adult life (average age of 30 years), but age at clinical onset varies considerably. The implications of the age of onset on the clinical presentation and course of MS are unclear. This population-based retrospective study presents data from a group of 125 patients with onset of MS before age 16 years and can thus be considered as representative of MS occurring in childhood. It demonstrates that childhood MS is more frequent in girls, that it very often has a relapsing-remitting course, that initial bouts usually involve afferent structures of the central nervous system, that recovery from these is often complete, and that the pace of the disease is slow.

摘要

多发性硬化症(MS)通常在成年早期发病(平均年龄30岁),但临床发病年龄差异很大。发病年龄对MS临床表现和病程的影响尚不清楚。这项基于人群的回顾性研究提供了一组125例16岁前发病的MS患者的数据,因此可被视为儿童期MS的代表。研究表明,儿童期MS在女孩中更为常见,通常具有复发-缓解病程,最初发作通常累及中枢神经系统的传入结构,这些发作后的恢复往往是完全的,且疾病进展缓慢。

相似文献

1
Multiple sclerosis in childhood: clinical profile in 125 patients.儿童多发性硬化症:125例患者的临床概况
J Pediatr. 1987 Sep;111(3):359-63. doi: 10.1016/s0022-3476(87)80454-7.
2
Clinical presentation of pediatric multiple sclerosis before puberty.儿童多发性硬化症青春期前的临床表现。
Eur J Neurol. 2014 Mar;21(3):441-6. doi: 10.1111/ene.12327. Epub 2013 Dec 16.
3
Clinical characteristics and long term prognosis in early onset multiple sclerosis.早发型多发性硬化症的临床特征及长期预后
J Neurol. 2006 Jun;253(6):720-3. doi: 10.1007/s00415-006-0095-1. Epub 2006 Mar 6.
4
Childhood and juvenile onset multiple sclerosis: clinical and paraclinical features.儿童及青少年起病的多发性硬化症:临床及辅助检查特征
Brain Dev. 2003 Jun;25(4):233-6. doi: 10.1016/s0387-7604(03)00034-2.
5
Pediatric multiple sclerosis: analysis of clinical and epidemiological aspects according to National MS Society Consensus 2007.
Arq Neuropsiquiatr. 2008 Sep;66(3B):665-70. doi: 10.1590/s0004-282x2008000500011.
6
[Clinical-epidemiological characteristics of late onset multiple sclerosis].[迟发性多发性硬化的临床流行病学特征]
Rev Neurol. 1997 Dec;25(148):1863-6.
7
Natural history of multiple sclerosis.多发性硬化症的自然病史。
Ann Neurol. 1994;36 Suppl:S6-11. doi: 10.1002/ana.410360704.
8
Early-Onset Multiple Sclerosis in Isfahan, Iran: Report of the Demographic and Clinical Features of 221 Patients.伊朗伊斯法罕早发性多发性硬化症:221例患者的人口统计学和临床特征报告
J Child Neurol. 2016 Jun;31(7):932-7. doi: 10.1177/0883073816634853. Epub 2016 Mar 15.
9
Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France.性别作为一种预后因素及其对法国洛林地区多发性硬化症发病率的影响。
J Neurol Sci. 2009 Nov 15;286(1-2):14-7. doi: 10.1016/j.jns.2009.07.012. Epub 2009 Aug 18.
10
Natural history of multiple sclerosis: a unifying concept.多发性硬化症的自然史:一个统一的概念。
Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16.

引用本文的文献

1
EARLY ONSET OF MULTIPLE SCLEROSIS - CLINICAL FEATURES.多发性硬化症的早期发病——临床特征
Acta Clin Croat. 2024 Apr;63(1):23-28. doi: 10.20471/acc.2024.63.01.3.
2
Pediatric Neuroimaging of Multiple Sclerosis and Neuroinflammatory Diseases.小儿多发性硬化症和神经炎性疾病的神经影像学
Tomography. 2024 Dec 20;10(12):2100-2127. doi: 10.3390/tomography10120149.
3
An Insight into Disseminated Acute Encephalomyelitis Pathogenesis and Treatment-A Review.播散性急性脑脊髓炎发病机制与治疗的深入探讨——综述
Curr Aging Sci. 2025;18(1):1-13. doi: 10.2174/0118746098294208240429091631.
4
Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS.特立氟胺在复发型多发性硬化症儿科患者中的应用:TERIKIDS 的开放标签扩展研究。
Mult Scler. 2024 Jun;30(7):833-842. doi: 10.1177/13524585241242050. Epub 2024 Apr 15.
5
Juvenile multiple sclerosis: addressing epidemiology, diagnosis, therapeutic, and prognostic updates along with cognitive dysfunction and quality of life.青少年多发性硬化症:探讨流行病学、诊断、治疗及预后的最新进展,以及认知功能障碍和生活质量。
Ann Med Surg (Lond). 2023 May 25;85(9):4433-4441. doi: 10.1097/MS9.0000000000000930. eCollection 2023 Sep.
6
Narrative review based on fingolimod therapy in pediatric MS.基于芬戈莫德治疗儿童多发性硬化症的叙述性综述。
SAGE Open Med. 2023 May 8;11:20503121231171996. doi: 10.1177/20503121231171996. eCollection 2023.
7
Treatable Ataxias: How to Find the Needle in the Haystack?可治疗的共济失调:如何在大海捞针?
J Mov Disord. 2022 Sep;15(3):206-226. doi: 10.14802/jmd.22069. Epub 2022 Sep 7.
8
Quantitative Meta-analyses of Cognitive Abilities in Children With Pediatric-onset Multiple Sclerosis.儿童多发性硬化症认知能力的定量荟萃分析
Neuropsychol Rev. 2023 Jun;33(2):459-473. doi: 10.1007/s11065-022-09546-3. Epub 2022 Jul 8.
9
Promising candidate cerebrospinal fluid biomarkers of seizure disorder, infection, inflammation, tumor, and traumatic brain injury in pediatric patients.小儿患者癫痫、感染、炎症、肿瘤及创伤性脑损伤的潜在脑脊液生物标志物。
Clin Exp Pediatr. 2022 Feb;65(2):56-64. doi: 10.3345/cep.2021.00241. Epub 2021 Aug 23.
10
Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis.缓释富马酸二甲酯在复发缓解型多发性硬化症儿科患者中的安全性和有效性
Front Neurol. 2021 Jan 4;11:606418. doi: 10.3389/fneur.2020.606418. eCollection 2020.